# Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System

> **NCT04410237** · EARLY_PHASE1 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DEVICE:** Med-Jet
- **OTHER:** Traditional Syringe

## Key facts

- **NCT ID:** NCT04410237
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-04
- **Primary completion:** 2023-05-19
- **Final completion:** 2023-05-19
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410237, "Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04410237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
